IL6 and arthritic joint disease: For instance, in a collagen-induced model of arthritis, treatment with a GSK3 inhibitor reduced joint inflammation and leukocyte infiltration and decreased the production of proinflammatory cytokine such as IL-1β, TNF, IL-6, and IFN-γ [63].